MHC expression in syngeneic and allogeneic retinal cell transplants in the rat.

Graefes Arch Clin Exp Ophthalmol

Department of Ophthalmology, Lund University Hospital, Sweden.

Published: January 1999

Background: The major histocompatibility complexes, MHC class I and II, are found only sparsely or not at all in the retina. Since the eye is immunoprivileged, we decided to investigate how the MHC class I and II antigens were influenced by a retinal transplant and whether this could be correlated to rejection of the transplant.

Methods: Fetal neural retinas of Sprague-Dawley (SD) rats were implanted in the subretinal space of adult Lewis and SD rats. After 5 weeks the retinas and the transplants were evaluated with antibodies against MHC class I and II antigens as well as microglia.

Results: In the syngeneic transplants no upregulation of MHC class I antigen was seen and no MHC class II-positive cells could be detected. In the allogeneic transplants, on the other hand, there was marked upregulation of MHC class I antigen. Numerous MHC class II antigen-positive cells were seen in the subretinal transplant but also in the host retina.

Conclusion: Allogeneic retinal transplants seem to grow and thrive just as well as syngeneic transplants, but in the former there is considerable upregulation of MHC expression. Our interpretation of these results is that the allogeneic transplants are recognized as nonself, but that there is also something that modifies this reaction of the immune system at this level, preventing the rejection that would normally ensue.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s004170050199DOI Listing

Publication Analysis

Top Keywords

mhc class
28
upregulation mhc
12
mhc
9
mhc expression
8
allogeneic retinal
8
class antigens
8
syngeneic transplants
8
class antigen
8
allogeneic transplants
8
transplants
7

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!